ASSURE Wearable Cardioverter Defibrillator (WCD) System
Kestra Medical Technologies, Inc. · Decision date Nov 4, 2026
What did the FDA decide?
The FDA recorded a 30-day notice decision, coded OK30, dated 2026-11-04 for supplement P200037/S022 to the ASSURE Wearable Cardioverter Defibrillator (WCD) System, a wearable automated external defibrillator (product code MVK, cardiovascular specialty) held by Kestra Medical Technologies, Inc. The supplement type is a 30-Day Notice and the recorded reason is a process change affecting manufacturer, sterilizer, packager or supplier.
The recorded statement describes the addition of a second-generation welding system. This entry documents that manufacturing process change within the existing PMA, not a new approval of the whole WCD system, and the source provides no detail on which components the welding system affects, what validation was reviewed, or the basis for the OK30 coding. No supporting documents were included in the source data, so those specifics remain unknown.
The source does not state whether the change alters device performance, labeling or clinical use, and no clinical or legal conclusion should be drawn from the decision code alone.
FDA approval order statement
addition of second-generation welding system
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Nov 4, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P200037/S022
- Regulatory pathway
- PMA supplement
- Applicant
- Kestra Medical Technologies, Inc.
- Product code
- MVK
- Decision code
- OK30
- Decision date
- Nov 4, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Wearable automated external defibrillator.
- Applicant
- Kestra Medical Technologies, Inc.
- Product code
- MVK
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P200037. Subsequent supplements may change the device or its indications.
FDA decision timeline
P200037 · Original PMA
ASSURE Wearable Cardioverter Defibrillator (WCD) System
P200037/S021 · Related supplement
ASSURE Wearable Cardioverter Defibrillator (WCD) System
P200037/S022 received
Application receipt date recorded by FDA.
P200037/S022 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P200037. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P200037
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Kestra Medical Technologies, Inc. | PMA approval | Jul 27, 2021 | FDA | |
| Kestra Medical Technologies, Inc. | PMA supplement | Sep 28, 2026 | FDA |
Explore the linked device profile
Other records with product code MVK
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LifeVest Wearable DefibrillatorP010030/S205 | Zoll Manufacturing Corporation | PMA supplement | Oct 6, 2026 | FDA |
LifeVest Wearable DefibrillatorP010030/S204 | Zoll Manufacturing Corporation | PMA supplement | Oct 5, 2026 | FDA |
LifeVest Wearable DefibrillatorP010030/S203 | Zoll Manufacturing Corporation | PMA supplement | Sep 29, 2026 | FDA |
LifeVest Wearable DefibrillatorP010030/S201 | Zoll Manufacturing Corporation | PMA supplement | Sep 9, 2026 | FDA |
| Zoll Manufacturing Corporation | PMA approval | Dec 18, 2001 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Kestra Medical Technologies, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 3933 Lake Washington Blvd. NE, Suite 200, Kirkland, WA, 98033
Sources and methodology
- Original FDA record: P200037/S022
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




